Modern Assessment Scores for Severe Community-Acquired Pneumonia: Perspectives and Limitations | CMAC

Modern Assessment Scores for Severe Community-Acquired Pneumonia: Perspectives and Limitations

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):204-213

​ Fesenko O.V., Sinopalnikov A.I.
community-acquired pneumonia severity guidelines
Section
Diseases and Pathogens
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):204-213

Abstract

Severe pneumonia is associated with high mortality rates, and appropriate severity assessment plays a main role in timely admission to the hospital, including intensive care unit. There are several scores for risk (poor outcome) assessment in patients with pneumonia. Each score has some advantages and disadvantages. This paper provides a review of current guidelines on the management of patients with severe community-acquired pneumonia.

  • 1. Заболеваемость населения России в 2007 г. Статистические материалы Минздравсоцразвития России, 2008.
  • 2. Restrepo MI, Mortensen EM, Rello J., et al. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 2010; 137:552-7.
  • 3. Fine M.J., Auble T.E., Yealy D.M., el al. A prediction rule to identify low risk patients with community acquired pneumonia. N Engl J Med 1997; 336:243-50.
  • 4. Atlas S.J., Benzer T.I., Borowsky L.H., et al. Safely increasing the proportion of patients with community acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 1998; 158:1350-6.
  • 5. Marrie T.J., Lau C.Y., Wheeler S.L., et al. A controlled trial of a critical pathway for treatment of community acquired pneumonia. CAPITAI Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin. JAMA 2000; 283:749-55.
  • 6. Angus D.C., Marrie T.J., Obrosky D.S., et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am J Respir Crit Care Med 2002; 166:717–23.
  • 7. Marrie T.J., Huang J.Q. Low risk patients admitted with community-acquired pneumonia. Am J Med 2005; 118:1357-63.
  • 8. Angus D.C., Marrie T.J., Obrosky D.S., et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am J Respir Crit Care Med 2002; 166:717-23.
  • 9. Ewig S., de Roux A., Bauer T., et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59:421-7.
  • 10. Valencia M., Badia J.R., Cavalcanti M., et al. Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007; 132:515-22.
  • 11. Restrepo M.I., Mortensen E.M., Velez J.A., et al. A comparative study of community-acquired pneumonia patients admitted to the Ward and the Intensive Care Unit. Chest 2008; 133:610-7.
  • 12. Fesenko O.V. Recognising poor prognosis communityacquired pneumonia in young adults with simple clinical measurement. Europ Respir J 2006; 28:351S.
  • 13. British Thoracic Society Research Committee and Public Health Laboratory Service. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir Med1992; 86:7-13.
  • 14. Conte H.A., Chen Y.T., Mehal W., et al. A prognostic rule for elderly patients admitted with communityacquired pneumonia. Am J Med 1999; 106: 20-8.
  • 15. Karalus N.C., Cursons R.T., Leng R.A., et al. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46:413-8.
  • 16. LimW.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia seventy on presentation to hospital: аn international derivation and validation study. Thorax 2003; 58:377-82.
  • 17. Niederman M.S, Feldman C., Richards G.A. Combining information from prognostic scoring tools for CAP: an American view on how to get the best of both worlds. Eur Resp J 2006; 27:9-11.
  • 18. Niederman M.S. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis 2010; 23:1-18.
  • 19. Capelastegui A., Espana P.P., Quintana J.M., et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Resp J 2006; 27:151-7.
  • 20. Bauer T.T., Fwig S., Marre R., et al. CRB-65 predicts death from community-acquired pneumonia. Intern Med 2006; 260:93-101.
  • 21. Chalmers J.D., Singanayagam A., Hill A.T. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008; 63:698-702.
  • 22. Aujesky D., Auble T.E., Yealy D., el al. Prospective comparison of three validated prediction rules for prognosis of community-acquired pneumonia. Am J Med; 2005: 118:384-92.
  • 23. Miyashita N., Matsushima T., Oka M. The JRS guidelines for the management of community-acquired pneumonia in adults: An update and new recommendations. Intern Med 2006: 45:419-28.
  • 24. Shindo Y., Sato S., Maruyama E., et al. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008: 13:731-5.
  • 25. Campbell G.D .Overview of community-acquired pneumonia: prognosis and clinical features. Med Clin North Am 1994; 78,1035-48.
  • 26. Niederman M.S., Mandell L.A., Anzueto A., et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
  • 27. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 2):S27-S72.
  • 28. Liapikou A., Ferrer M., Polverino E., et al. Severe community-acquired pneumonia: validation of the IDSA/ ATS guidelines to predict admission to the ICU. Clin Infect Dis 2009; 48:377-05.
  • 29. Espana P.P., Capelastegui A., Gorordo I., et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174:1249-56.
  • 30. Charles P.C., Wolfe R., Whitby M., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community acquired pneumonia. Clin Infect Dis 2008; 47:375-81.
  • 31. Chalmers J.D., Singanayagam A., Hill A.T. Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin Infect Dis 2008; 47:1571-4.
  • 32. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2003; 31:1250-6.
  • 33. Rello J.R., Rodriguez A., Lisboa T., et al. PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 2009; 37:456-62.
  • 34. Labarere J., Stone R.A., et al. Factors associated with the hospitalization of low-risk patients with communityacquired pneumonia in a cluster-randomized trial. J Gen Intern Med 2006; 21:745-52.
  • 35. Lim W.S., Macfarlane J.T. Defining prognostic factors in the elderly with community-acquired pneumonia: a case controlled study of patients aged ≥75 years. Eur Respir J 2001; 17:200-5.
  • 36. Lim W.S., Lewis S., Macfarlane I.T. Severity prediction rules in community-acquired pneumonia: a validation study. Thorax 2000; 55:219-23.
  • 37. Naito T., Suda T., Yasuda K., et al. A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia. J Am Geriat Soc 2006; 54:1212-9.
  • 38. Chi R.C., Jackson L.A., Neuzil K.M. Characteristics and outcomes of older adults with community-acquired pneumococal bacteremia. J Am Geriair Soc 2006; 54:115- 20.
  • 39. van der Steen J.T., Mehr D.R., Kruse R.L., et al. Dementia, lower respiratory tract infection, and mortality. J Am Med Dir Assoc 2007; 8:396-403.
  • 40. El-Solh A.A., Pineda L., Bouquin P., et al. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr 2006; 6:12.
  • 41. Myint P.K., Kamath A.V., Vowler S.L. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation. age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006; 35:286-91.
  • 42. Goss C.H., Rubenfeld G.D., Park D.R., el al. Cost and incidence of social comorbidities in low-risk community acquired pneumonia patients admitted to a public hospital. Chest 2003; 124:214-21.
  • 43. Stelianides S., Golmard ].L., Carbon C., Bantin B. Influence of socioeconomic status on features and outcome of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1999; 18:704-8.
  • 44. Fine M.J., Hough L.I., Medsger A.R., et al. The hospital admission decision for patients with communityacquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157:36-44.
  • 45. Fine M.J., Medsger A.R., Stone R.A., et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 1997; 157:47-56.
  • 46. Restrepo M.I., Mortensen E.M., Jacqueline A., et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Resp J 2006; 28:346-51.
  • 47. Sanders K.M., Marias T.K., Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13:89-93.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared